In the past week, MIRA stock has gone down by -11.70%, with a monthly decline of -30.06% and a quarterly surge of 75.35%. The volatility ratio for the week is 11.07%, and the volatility levels for the last 30 days are 11.58% for Mira Pharmaceuticals Inc The simple moving average for the past 20 days is -25.23% for MIRA’s stock, with a 1.15% simple moving average for the past 200 days.
Is It Worth Investing in Mira Pharmaceuticals Inc (NASDAQ: MIRA) Right Now?
The 36-month beta value for MIRA is at 4.61. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MIRA is 9.96M, and currently, shorts hold a 5.96% of that float. The average trading volume for MIRA on September 18, 2024 was 5.69M shares.
MIRA) stock’s latest price update
The stock price of Mira Pharmaceuticals Inc (NASDAQ: MIRA) has plunged by -4.96 when compared to previous closing price of 1.31, but the company has seen a -11.70% decline in its stock price over the last five trading sessions. accesswire.com reported 2024-09-18 that MIAMI, FL / ACCESSWIRE / September 18, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing innovative therapies for neurologic and neuropsychiatric disorders, today announced significant progress in the clinical development planning for its novel oral ketamine analog. As part of its strategic development plan, MIRA is prioritizing the early demonstration of clinical efficacy, potentially as early as 2025, through innovative Phase I/II study designs.
MIRA Trading at -29.91% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.79% of loss for the given period.
Volatility was left at 11.58%, however, over the last 30 days, the volatility rate increased by 11.07%, as shares sank -33.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +137.95% upper at present.
During the last 5 trading sessions, MIRA fell by -8.48%, which changed the moving average for the period of 200-days by -63.65% in comparison to the 20-day moving average, which settled at $1.6325. In addition, Mira Pharmaceuticals Inc saw 18.57% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Brian McNulty, who proposed sale 10,000 shares at the price of $1.80 back on Sep 04 ’24. After this action, Brian McNulty now owns shares of Mira Pharmaceuticals Inc, valued at $18,000 using the latest closing price.
McNulty Brian Patrick, the 10% Owner of Mira Pharmaceuticals Inc, sale 200,000 shares at $1.96 during a trade that took place back on Aug 28 ’24, which means that McNulty Brian Patrick is holding 2,540,270 shares at $392,000 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -4.38. Equity return is now at value -748.59, with -373.77 for asset returns.
Currently, EBITDA for the company is -8.53 million with net debt to EBITDA at 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.68.
Conclusion
In conclusion, Mira Pharmaceuticals Inc (MIRA) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
